Regulatory & Legal

A federal by-election is set for Scarborough Southwest after Bill Blair's departure, with the Liberals quickly naming a high-profile former NDP MPP.

The Department of War is deploying a commercial AI to break language barriers, turning a year-long translation project into a few weeks' work. Here's how.

A new partnership brings acute end-of-life care into a residential setting, allowing Austin seniors to receive critical support without leaving home.

A $12M deal for natural gas fuel systems signals a major shift from diesel in Mexico's trucking industry, promising huge cost and emissions savings.

As Erie prepares its 2025 results, investors eye underwriting profit, premium growth, and future guidance in a turbulent insurance market.

A retired anesthesiologist suffers a catastrophic brain injury during surgery. Now, her family is taking a major healthcare provider to trial for negligence.

After flawless human trials, a Chapel Hill startup secures funding to bring its revolutionary ultrasound-based blood clot treatment to the United States.

Despite a crippling storm, the D.C. Auto Show thrived, highlighting local culture, national policy debates, and a surprising pivot in the auto industry.

A multi-year deal for Iron Dome parts highlights a strategic shift, validating Nukkleus' focus on the defense industry's vital Tier-2 suppliers.

As fraudulent hospice claims top $3 billion, a new private certification program hopes to restore trust and protect vulnerable end-of-life patients.

Gartner recognizes ETQ for its visionary QMS platform as the industry tackles supply chain risks and embraces data-driven, automated quality management.

UK insurers face a tight deadline for tough new PRA collateral rules. A new solution from Transcend aims to ease the burden and enhance risk oversight.

A major multi-vendor study confirms AI's power for precision HER2 scoring, promising to improve diagnostics and accelerate personalized cancer therapies.

Quanterix has submitted a multi-biomarker blood test to the FDA, a move that could revolutionize early Alzheimer's diagnosis and patient care.

A bipartisan bill in Congress aims to give veterans access to emerging mental health treatments, including the novel, non-hallucinogenic compound MEAI.

A new FDA-approved device offers a drug-free alternative for severe rheumatoid arthritis. Rush University is the first in Chicago to implant the system.

A new report reveals AI-powered disinformation is bypassing firewalls, costing billions. Experts say firms are dangerously unprepared for this new reality.

Eli Lilly partners with China's Zonsen PepLib, betting on its novel peptide platforms to fuel the next wave of therapies in oncology and metabolism.

A new partnership aims to slash waste and streamline clinical trials, heralding a tech-driven transformation in the backbone of drug development.

The rehab therapy software giant capped a pivotal year with key AI partnerships, a new executive team, and a major push into remote care, signaling its next era.